Healthcare provider profile · identity verified

Brian Chenghui Li, D.O.

Family Practice · BROOKLYN, NY · NPI 1699904151

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Vascepa	Icosapent Ethyl	569	133
Simvastatin	Simvastatin	443	129
Losartan Potassium	Losartan Potassium	418	105
Atorvastatin Calcium	Atorvastatin Calcium	343	88
Amlodipine Besylate	Amlodipine Besylate	302	85
Metformin Hcl	Metformin Hcl	298	77
Tamsulosin Hcl	Tamsulosin Hcl	263	62
Diclofenac Epolamine	Diclofenac Epolamine	213	74
Meclizine Hcl	Meclizine Hcl	192	95
Azithromycin	Azithromycin	191	125
Omeprazole	Omeprazole	185	74
Mometasone Furoate	Mometasone Furoate	183	90
Montelukast Sodium	Montelukast Sodium	133	40
Amoxicillin	Amoxicillin	120	84
Metoprolol Succinate	Metoprolol Succinate	115	32
Albuterol Sulfate Hfa	Albuterol Sulfate	113	39
Hydroxyzine Hcl	Hydroxyzine Hcl	102	43
Alendronate Sodium	Alendronate Sodium	96	30
Ammonium Lactate	Ammonium Lactate	93	54
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	22
Azelastine Hcl	Azelastine Hcl	85	58
Chlorhexidine Gluconate	Chlorhexidine Gluconate	85	42
Alcohol Prep Pads	Alcohol Antiseptic Pads	84	28
Triamcinolone Acetonide	Triamcinolone Acetonide	84	47
Lisinopril	Lisinopril	81	21
Fluticasone Propionate	Fluticasone Propionate	78	48
Levothyroxine Sodium	Levothyroxine Sodium	75	17
Esomeprazole Magnesium	Esomeprazole Magnesium	71	20
Januvia	Sitagliptin Phosphate	71	14
Finasteride	Finasteride	69	20
Hydrochlorothiazide	Hydrochlorothiazide	69	22
Ciprofloxacin Hcl	Ciprofloxacin Hcl	66	52
Zolpidem Tartrate	Zolpidem Tartrate	66	20
Mupirocin	Mupirocin	63	52
Famotidine	Famotidine	61	39
Raloxifene Hcl	Raloxifene Hcl	60	14
Rosuvastatin Calcium	Rosuvastatin Calcium	60	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	59	46
Meloxicam	Meloxicam	59	34
Atenolol	Atenolol	57	13
Clobetasol Propionate	Clobetasol Propionate	56	26
Donepezil Hcl	Donepezil Hcl	56	27
Diclofenac Sodium	Diclofenac Sodium	54	45
Gabapentin	Gabapentin	53	17
Loperamide	Loperamide Hcl	51	34
Farxiga	Dapagliflozin Propanediol	49	12
Glipizide Er	Glipizide	47	11
Dicyclomine Hcl	Dicyclomine Hcl	46	36
Tradjenta	Linagliptin	46	suppressed
Bepotastine Besilate	Bepotastine Besilate	45	18
Naproxen	Naproxen	44	25
Allopurinol	Allopurinol	42	suppressed
Jardiance	Empagliflozin	42	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	38	17
Dexlansoprazole Dr	Dexlansoprazole	36	12
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Nexium	Esomeprazole Magnesium	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Procto-Med Hc	Hydrocortisone	32	18
Colchicine	Colchicine	31	15
Enalapril Maleate	Enalapril Maleate	31	suppressed
Halobetasol Propionate	Halobetasol Propionate	31	18
Hydrocortisone	Hydrocortisone	31	18
Lidocaine-Prilocaine	Lidocaine/Prilocaine	30	21
Alcohol Pads	Alcohol Antiseptic Pads	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	15
Pantoprazole Sodium	Pantoprazole Sodium	27	11
Glipizide-Metformin	Glipizide/Metformin Hcl	25	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Felodipine Er	Felodipine	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Ibuprofen	Ibuprofen	22	18
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Glipizide	Glipizide	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Eliquis	Apixaban	20	suppressed
Icosapent Ethyl	Icosapent Ethyl	20	16
Potassium Citrate Er	Potassium Citrate	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Ofloxacin	Ofloxacin	16	12
Synthroid	Levothyroxine Sodium	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	15	suppressed
Restasis	Cyclosporine	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Acarbose	Acarbose	13	suppressed
Adefovir Dipivoxil	Adefovir Dipivoxil	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Furosemide	Furosemide	12	suppressed
Lactulose	Lactulose	12	suppressed
Metformin Er Gastric	Metformin Hcl	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Calcium Acetate	Calcium Acetate	11	suppressed
Comfort Ez Pro Safety Pen Ndl	Pen Needle, Diabetic, Safety	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error